Researchers at Osaka Metropolitan University report that stem cells taken from body fat, formed into bone-leaning spheroids and paired with a common bone-reconstruction material, improved healing and strength in rat models of osteoporotic vertebral fractures. The preclinical findings, published in Bone & Joint Research, point to a potential future therapy if validated in humans.
Osteoporosis weakens bones and raises the risk of fractures as populations age. In Japan, recent estimates place the number of people with the condition at roughly 15–16 million. Vertebral compression fractures are the most common osteoporotic fractures and can lead to long-term disability and reduced quality of life.
A team led by Graduate School of Medicine student Yuta Sawada and Dr. Shinji Takahashi at Osaka Metropolitan University investigated adipose-derived stem cells (ADSCs), which can mature into bone-forming cells. The researchers cultivated ADSCs into three‑dimensional spheroids and pre‑differentiated them toward an osteogenic state to enhance their repair potential.
They then combined these spheroids with β‑tricalcium phosphate, a widely used bone‑reconstruction material, and applied the mixture to rats with vertebral defects designed to mimic osteoporotic fractures. Compared with controls, treated animals showed greater bone regeneration on imaging and histology and withstood higher loads in compression tests, indicating stronger repair. The team also observed increased activity of genes associated with bone formation and tissue regeneration.
“This study has revealed the potential of bone differentiation spheroids using ADSCs for the development of new treatments for spinal fractures,” Sawada said. “Since the cells are obtained from fat, there is little burden on the body, ensuring patient safety.”
Dr. Takahashi added, “This simple and effective method can treat even difficult fractures and may accelerate healing. This technique is expected to become a new treatment that helps extend the healthy life of patients.”
The study, published on October 28, 2025, in Bone & Joint Research, reports results in rats. Further studies will be needed to assess safety and efficacy in people.
